Swedish Orphan Biovitrum total non-operating income/expense for the twelve months ending September 30, 2024 was $-0.130B, a 55.79% increase year-over-year.
Swedish Orphan Biovitrum annual total non-operating income/expense for 2024 was $-0.115B, a 9.97% increase from 2023.
Swedish Orphan Biovitrum annual total non-operating income/expense for 2023 was $-0.105B, a 115.07% increase from 2022.
Swedish Orphan Biovitrum annual total non-operating income/expense for 2022 was $-0.049B, a 4.53% decline from 2021.
Swedish Orphan Biovitrum Total Non-Operating Income/Expense 2019-2024 | BIOVF